Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. - Wikidata - wikimedia - TriplyDB

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

http://www.wikidata.org/entity/Q35824836

about

Antihypertensive agents for preventing diabetic kidney disease Antiproteinuric effect of calcium antagonists on puromycin-induced experimental nephrosis Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.Renoprotective role of ACE inhibitors in diabetic nephropathy Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes and hypertension.Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview.Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.Evidence-based treatment of hypertension in patients with type 2 diabetes.Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.Calcium channel blockers in the prevention of end stage renal disease: a review.Prevention of type 2 diabetes and its complications in developing countries: a review.Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).The diabetic patient with hypertension.The healthcare burden of hypertension in Asia.Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study.Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.Antihypertensive therapy for the prevention of nephropathy in diabetic hypertensive patients.Dihydropyridine calcium channel blockers and renal disease.Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.Design of cost-effective packages of care for non-insulin-dependent diabetes mellitus. Defining the information needs.Adherence to available clinical practice guidelines for initiation of antihypertensive medication in patients with or without diabetes mellitus and other comorbidities in Taiwan.

P2860

Q24202090-62F44C90-2919-4E60-B663-D240F91397C4 Q28373239-A47D6663-4AA0-4714-945D-CB6A9A84C7B8 Q30251636-973E0ED9-899A-472A-B187-E6910F6D9379 Q33614282-E6EF62B2-CB99-418D-9AC9-956533794298 Q33643752-17E49C89-D66C-45B4-ABB5-C451B4C5B24E Q33886870-7EEAA1FC-61BF-45BC-A4E7-8AB7F11D8BF1 Q33917790-4D26220A-A15E-431F-B9C8-98B5E81C6CA7 Q34075171-1CBF54FC-BCEF-4B54-BD48-E43D0EBC71D7 Q34267980-A0A00C6C-2D49-4539-A64F-03D1DAA8D454 Q34849534-2135D366-9858-467C-A621-1DB1F5357E54 Q35738806-DAEE29B1-07C1-4509-B7DF-D17E42AECB5E Q35981529-2F75C9ED-DFCC-4D98-BB93-299F95C140D4 Q36456306-82748221-9F89-4A57-98A3-6F1447D8E178 Q36680739-80C8F3C6-9425-41A5-B16C-29D17D13C14F Q36801003-6C07C3AF-01A6-4554-96B8-3361B54D2C9B Q37202153-03067386-92DB-482B-9D90-240B88A5EFCE Q37419587-4A2B2930-A650-4DF2-9FAD-217AB0622ABF Q37629831-4030D172-1522-45F8-857C-9D66CD171A37 Q38724392-2DD1A95A-F9DB-4334-846D-4612B0932938 Q38895879-92B8E79D-687A-41F5-AE17-4E83DFDB63B8 Q40884232-A8B35CF9-59AD-40F8-9911-3BCF0700342A Q41600402-A98CB021-2786-4F00-A381-5C0584D5ED48 Q45419925-B00AA78D-132F-466A-A4FF-2D59617F1736

P2860

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

http://www.wikidata.org/entity/Q35824836

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Comparison of enalapril and ni ...... pertension: one year analysis.

@ast

Comparison of enalapril and ni ...... pertension: one year analysis.

@en

type

label

Comparison of enalapril and ni ...... pertension: one year analysis.

@ast

Comparison of enalapril and ni ...... pertension: one year analysis.

@en

prefLabel

Comparison of enalapril and ni ...... pertension: one year analysis.

@ast

Comparison of enalapril and ni ...... pertension: one year analysis.

@en

P1433

Q35824836-CED416F3-C04E-4674-960C-3720CFEC7F49

P1476

Q35824836-E52076B5-910D-4894-BDFF-0E532C40D29E

P2093

Q35824836-0D0D5EA5-18D0-41C6-BCD4-F8C2FE7B33DA

Q35824836-9D5E180D-A448-44D1-9424-8E7AD81676C4

Q35824836-E4DA67EA-FAB1-4BBB-9972-D604E7CFAD2C

Q35824836-F35F67F2-707A-413F-B099-BA0BB82524D2

Q35824836-FC86F5B8-FA03-4646-8DA8-9C00843D55EA

P2860

Q35824836-05215E8E-BD00-4869-BB2B-E617FBD80888

Q35824836-10A60D78-B79E-4A2B-9B2A-285E07A413D5

Q35824836-1B811506-5330-48D9-9C4E-032692C1D021

Q35824836-4ACEF385-DD6B-44A6-9315-EE9A5E782BD7

Q35824836-5A321374-33FB-4EC4-8F41-5C62F44E411B

Q35824836-7944E951-EE9D-4084-ACFB-C0DC4349A7CA

Q35824836-9527193E-76F4-4FF8-83B9-5C14E947D081

Q35824836-A075C1AD-3AA2-4011-AE52-59E9268E41C5

Q35824836-A0A590FB-34EA-4FEF-B0BB-786FA1A60BA8

Q35824836-BC403FD6-F33E-40A4-BD7D-9F4AB8619431

P304

Q35824836-8496B477-C7C4-413D-A543-E3A8E6E15071

P31

Q35824836-12355CE5-00B7-4DF2-B585-0CC324336B1F

P356

Q35824836-28122585-3523-4CF9-8CCE-7788DA149ACF

P407

Q35824836-F5300133-FD54-4F41-8221-0FAAFFE01C1E

P433

Q35824836-4679E652-1FC7-4286-92F9-64701CAD01B2

P478

Q35824836-52962CA4-7565-46A2-BA7A-04C0A70BE3B1

P577

Q35824836-FFC94F28-3C51-4EA5-B6A4-0B34253178F6

P5875

Q35824836-6AC5D96E-2056-4BE1-BBBB-6002276494A3

P698

Q35824836-1BC62BD3-1257-4390-ABD5-BEB693D0976E

P932

Q35824836-26F95FC8-F1AF-4A48-94A0-ED4C82972792

P356

BMJ.305.6860.981

P1433

P1476

Comparison of enalapril and ni ...... pertension: one year analysis.

@en

P2093

Chan JC

http://www.w3.org/2001/XMLSchema#string

Cheung CK

http://www.w3.org/2001/XMLSchema#string

Cockram CS

http://www.w3.org/2001/XMLSchema#string

Nicholls MG

http://www.w3.org/2001/XMLSchema#string

Swaminathan R

http://www.w3.org/2001/XMLSchema#string

P2860

Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatment

Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy.

Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure

Drug-induced disturbances of carbohydrate metabolism.

Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine.

Type 2 (non-insulin-dependent) diabetes--an epidemiological overview.

Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.

Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus.

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

Angiotensin converting enzyme inhibitors and diabetic nephropathy.

P304

981-985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.305.6860.981

http://www.w3.org/2001/XMLSchema#string

P407

P433

6860

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

1992-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21697863

http://www.w3.org/2001/XMLSchema#string

P698

1458144

http://www.w3.org/2001/XMLSchema#string

P932

1883996

http://www.w3.org/2001/XMLSchema#string